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Background: Insulin signalling contributes to diverse cellular 
activities including protein synthesis, proliferation and cell survival. 
Insulin resistance describes the inability of cells to activate the insulin 
signalling pathway effectively; leading to pathological effects in 
multiple organ systems including the kidney. In diabetic kidney 
disease, there is progressive glomerular dysfunction and recent 
studies have demonstrated that the kidney podocyte is a direct target 
for insulin action. In this study we defined the literature-based insulin 
receptor (INSR) interactome and utilised an unbiased proteomic 
approach to examine INSR interactors in podocytes. 
Methods: Human podocytes expressing the INSR were characterised 
under basal and insulin resistant conditions. The INSR was isolated by 
whole cell immunoprecipitation following a time course stimulation of 
2, 7, and 15 minutes with of 100nM insulin. The resulting INSR 
complexes were analysed by label-free mass spectrometry (MS) to 
detect protein interactors. 
Results: We identified 27 known, direct INSR interactors in addition to 
novel interactors including doublecortin domain-containing protein 2 
(DCDC2). The interaction of DCDC2 with the INSR was confirmed by 
immunoprecipitation and immunofluorescence, and under insulin 
resistant conditions, DCDC2 had increased association with the INSR. 
siRNA knockdown of DCDC2 in podocytes resulted in cell 
morphological change and altered INSR localisation. 
Conclusion: This study provides insight into the complexity of INSR 
interactors in podocytes and highlights DCDC2 as a novel INSR 
binding protein. Involvement of this novel interactor in insulin 
signalling and podocyte biology may explain how insulin resistance 
alters morphology and integrity of the glomerular filtration barrier.
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Introduction
Insulin plays a key role in energy homeostasis and insulin 
signalling contributes to diverse cellular activities including 
protein synthesis, proliferation and cell survival1. Abnormal 
physiological conditions and disease processes can interfere 
with the insulin signalling pathway leading to complete or 
partial loss of downstream effects. This state is known as 
insulin resistance2, which describes the inability of cells to 
activate the insulin signalling pathway effectively leading to 
pathological effects in multiple organ systems including 
muscle, liver, and kidneys3,4. Insulin resistance is associated 
with high levels of the free fatty acid palmitate and palmitate 
has been shown to induce cellular insulin resistance in a number 
of cell types5–7.
Type 2 diabetes has a huge global prevalence with more than 
500 million individuals affected worldwide8. Insulin resistance 
is a hallmark feature and poor glycaemic control can lead to 
multiple secondary complications including diabetic kidney 
disease (DKD). 30–40% of individuals with either type 1 or 
type 2 diabetes develop DKD, which is a leading cause of 
chronic kidney disease worldwide9. In the early stages of DKD 
the kidney glomerulus undergoes hypertrophy and there is 
progressive deposition of extracellular matrix, associated 
with thickened basement membranes and mesangial matrix 
expansion10. With progression there is podocyte foot process 
effacement leading to albuminuria, which is an early clinical 
feature of DKD. A number of studies have demonstrated that 
among the different cell types in the kidney, the podocyte is a 
direct target for insulin action, and the abrogation of insulin 
signalling specifically in these cells can cause progressive kidney 
damage and CKD5,11,12.
Podocytes are terminally differentiated, specialised epithelial 
cells and are located on the outer surface of glomerular cap-
illaries. These cells are known for their unique morphology 
featuring large cell bodies, primary processes, and interdigitat-
ing foot processes. Podocytes are insulin-sensitive cells and 
capable of rapidly transporting glucose via the transporter 
GLUT43. Furthermore, deletion of the insulin receptor (INSR) in 
podocytes demonstrated the key role of this signalling axis as 
mice developed albuminuria with associated podocyte foot 
process effacement and altered extracellular matrix, mimicking 
features of DKD in humans11. The unique morphology of 
podocytes is influenced by tight regulation of cytoskeletal 
components13 and therapeutic targeting of actin-dependent 
dynamin oligomerisation has been proposed as a therapeutic 
strategy14. Whilst a number of studies have focussed on 
defining podocyte protein interaction networks15,16 to elucidate 
mechanisms of disease, a primary focus on the INSR is lacking.
This study utilised mass spectrometry (MS)-based proteomics 
to examine INSR interactors in podocytes under healthy 
conditions. The primary aim was to identify known and novel 
INSR interactors and the secondary aims were to: 1) examine 
novel interactors in the context of palmitate-induced insulin 




Antibodies used were against mouse anti-insulin receptor 
(INSR beta Monoclonal Antibody (CT-1), Thermo Fisher 
Scientific, catalogue number: MA5-13778),17, rabbit anti-AKT 
(Polyclonal antibody, Cell Signalling Technology, catalogue 
number: 9272)18, rabbit anti- AKT [pS473] (Polyclonal antibody, 
Cell Signalling Technology, catalogue number: 9271)19, 
rabbit anti- p44/42 MAPK (Erk1/2) (Polyclonal antibody, Cell 
Signalling Technology, catalogue number: 9102)20, rabbit anti- 
Phospho-p44/42 MAPK (Erk1/2) (Thr202/Tyr204) (Polyclo-
nal antibody, Cell Signalling Technology, catalogue number: 
4370)19, mouse anti-IRS1 (IRS-1 monoclonal antibody, Cell 
Signalling Technology, catalogue number: L3D12)21, rabbit 
anti-phospho-IRS1 (Tyr608) mouse/ (Tyr612) human Antibody 
(Polyclonal antibody, Merck Millipore, cat# 09-432)22, goat 
anti-DCDC2 (polyclonal antibody, Abcam, catalogue number: 
ab45868, western blotting dilution [1:1000], Immunofluores-
cent imaging [1:250]), mouse anti-Actin (monoclonal antibody, 
Sigma-Aldrich, catalogue number: A4700, Clone AC-40)23, 
mouse anti-Beta1 integrin (monoclonal antibody, Sigma-Aldrich, 
catalogue number: MAB1965, a.a. 82-87, clone JB1A)24. Alexa 
Fluor 488 Phalloidin molecular probe was used for detecting 
actin filaments (Thermo Fisher Scientific, catalogue number: 
A12379)25 and tubulin was detected with rat anti-alpha tubulin 
(YL1/2) (monoclonal antibody, Thermo Fisher Scientific, 
catalogue number: MA1-80017)26 or mouse anti-beta tubulin 
(monoclonal antibody, Thermo Fisher Scientific, catalogue 
number: MA5-16308). Secondary antibodies conjugated to 
AlexaFluor 680 (Donkey anti-rabbit polyclonal antibody, Life 
Technologies, catalogue number: A10043)27 were used for 
immunofluorescence and IRDye 800 (Goat polyclonal antibody 
anti-mouse, Rockland antibodies and assays, catalogue number: 
610-145-121)28 were used for western blotting.
Cell culture
Conditionally immortalised mouse and human podocytes were 
kindly provided by Moin A. Saleem and Richard J. Coward 
and were cultured as previously described29. Briefly, podocytes 
between passage 10 and 16 were grown in uncoated tissue 
culture plates in RPMI-1640 medium with glutamine 
(R-8758; Sigma-Aldrich) supplemented with 10% (v/v) foetal 
calf serum (Life Technologies) and 5% (v/v) ITS (I-1184; 
Sigma-Aldrich; 1 ml/100 ml). Initially cells were cultured at 
33°C for proliferation and then switched to 37°C for 10–14 days 
for differentiation into mature podocytes. Insulin stimulation 
was based on previously described work30. Briefly, cells were 
cultured in RPMI-1640 medium without ITS or growth factors 
for 16 hours, followed by 100 nm insulin stimulation for 
15 minutes as a default setup, or for different time intervals for 
time-course experiments. The insulin-containing media was 
then removed, and the cells washed by ice-cold PBS. Inducing 
insulin resistance in podocytes followed a previously described 
method with modifications5. Briefly, the standard culture 
medium was supplemented with 5% (w/v) fatty acid free 
bovine serum albumin (BSA), 750 µM palmitate, and 1%(v/v) 
ethanol. The control cells were cultured in the same medium 
without palmitate but with 1%(v/v) ethanol. Cells were incubated 
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with palmitate for 24 hours and prior to insulin stimulation 
cells were serum starved in RPMI-1640 medium without ITS 
or growth factors and supplemented with 5% (w/v) fatty acid 
free BSA, 750 µM palmitate, and 1% (v/v) ethanol or without 
palmitate for control cells.
siRNA knockdown
ON-TARGETplus® DCDC2 siRNA SMARTpool and non- 
targeting siRNA were obtained from (Cat#: L-020868-02-0050, 
Dharmacon, Colorado, USA). Podocytes were grown to approxi-
mately 90–95% confluence and RNAi-mediated knockdown 
was performed using Lipofectamine 2000 (Invitrogen) and 
specific siRNA oligonucleotides in the presence of Opti-MEM 
according to manufacturer’s instructions. The siRNA oligonu-
cleotides and Lipofectamine 2000 were diluted independently 
in Opti-MEM at a ratio of 1:5 per well for a 6 well tissue 
culture plate, and then incubated at room temperature for 
5 minutes. The two components were then combined and 
further incubated at room temperature for 40 minutes. The 
media was removed from cells and the transfection mixture 
added in a 1:1 ratio with complete cell culture media. The cells 
were incubated for 4–6 hours before converting to normal 
growth medium.
2-NBDG glucose uptake
These experiments using a fluorescent indicator for direct 
glucose uptake were based on the previously described method 
with modifications31. Podocytes were cultured and differentiated 
in 100mm plates, and a single plate was used per condition. 
Cells were serum starved for a minimum of 2-12 hours and 
then supplemented with or without 200 µM 2-[N-(7-nitrobenz- 
2-oxa-1,3-diazol-4-yl) amino]-2-deoxy-D-glucose (2-NBDG) 
dissolved in serum free medium for 1 hour at 37°C. Cells were 
then washed twice with ice-cold PBS, and lysed in 100 µl 
ice-cold lysis buffer. 70 µl of the cell lysate was used for 
assessing the 2-NBDG uptake in cells using a fluorescent 
plate reader, while the remaining 30 µl was used for quantifying 
the total protein of the samples using bicinchoninic acid assay 
(BCA assay) (Thermo Fisher catalogue number: 23225).
Immunoprecipitation of the INSR and detection by mass 
spectrometry
Protein G magnetic dynabeads® (Thermo Fisher catalogue 
number: 10004D) were aliquoted to Eppendorf tubes, washed 
once with PBS, and re-suspended in 0.02% (v/v) PBS-T (PBS, 
0.02% Tween) buffer. The mouse anti-insulin receptor antibody 
(beta subunit) (clone CT-1; Thermo Scientific) was added to the 
beads and incubated for 16 hours in 4°C with rotation. Beads 
were washed twice with 0.02% (v/v) PBS-T buffer, and then 
re-suspended in 630 µl [0.15 M NaCl (pH 7.8)]. 2 mg of bis(su
lfosuccinimidyl)suberate (BS3) crosslinker was re-suspended 
in 70 µl MilliQ H
2
O and then added to the beads, and the 
beads were incubated for 2 hours on ice with mixing at an 
interval of 30 minutes. The BS3 crosslinker was quenched by 
adding 100 mM Tris buffer for 10 minutes at room temperature 
with rotation. The beads were washed twice with 0.02% (v/v) 
PBS-T buffer and stored at 4°C until needed. The cells were 
lysed in an immunoprecipitation buffer (ThermoFisher, Pierce™ 
IP Lysis Buffer catalogue number: 87787) supplemented with 
phosphatases and proteases inhibitors (ThermoFisher, Halt™ 
Protease and phosphatase Inhibitor Cocktail, EDTA-free 
catalogue number: 78445). The cell lysate was kept on ice for 
30 minutes with vortexing every 10 minutes, and then centri-
fuged at 14000 rpm for 10 minutes at 4°C using a benchtop 
centrifuge. The supernatant was transferred to a clean tube 
and kept on ice, and the pellet was discarded. The pre-coated 
beads were added to the cell lysate and incubated for 2–4 hours 
at 4°C with rotation, and then the lysate was transferred to a 
new tube (the flow through, which is the unbound receptor 
fraction) and the beads were eluted in SDS sample buffer for 
10 minutes at 95°C. The eluted complexes were transferred to 
a new tube, and the beads were discarded.
MS sample preparation
As previously32, for in-gel proteolytic digestion, gel lanes 
were cut into slices and each slice cut into ~1 mm3 pieces. Gel 
pieces were de-stained three times with (50% (v/v) acetonitrile 
and 50% (v/v) 25mM NH4 HCO3) solution for 30 minutes to 
remove protein stain, and then dehydrated by immersing in 
acetonitrile followed by vacuum centrifugation for 1 hour. The 
proteins were reduced in 10 mM DTT, alkylated in 55 mM 





and acetonitrile. The gel pieces were dehy-
drated using a vacuum centrifuge and then rehydrated and 
digested with sequencing grade trypsin (12.5 ng/µl in 25mM 
NH4 HCO3) at 37°C overnight. Peptides from the gel slices 
were collected in single wash of (99.8% (v/v) acetonitrile, and 
0.2% (v/v) formic acid) and single wash of (50% (v/v) acetonitrile 
and 0.1% (v/v) formic acid). Peptides were desiccated in a 
vacuum centrifuge and re-suspended in 50 µl of (5% (v/v) 
acetonitrile and 0.1% (v/v) formic acid). To desalt peptides, each 
sample was resuspended in 5% (v/v) acetonitrile in 0.1% (v/v) 
formic acid followed by incubation with OLIGOTM R3 beads 
(Applied Biosystems, Paisley, UK). Bead-bound peptides 
were washed twice in 0.1% (v/v) formic acid, eluted by two 
washes in 50% (v/v) acetonitrile in 0.1% (v/v) formic acid, 
dried and resuspended in 5% (v/v) acetonitrile in 0.1% (v/v) 
formic acid.
MS data acquisition, data analysis and data deposition
The analysis of the samples by the MS instruments was 
performed through the Biological Mass Spectrometry core 
facility at the University of Manchester. Peptides were analysed 
by liquid chromatography-tandem mass spectrometry 
(LC-MS/MS) using an UltiMate 3000 Rapid Separation LC 
(RSLC, Dionex Corporation, Sunnyvale, CA, USA) coupled to an 
Orbitrap Elite mass spectrometer (Thermo Fisher Scientific). 
Peptide samples were separated on an analytical column (250mm 
× 75 µm i.d., 1.7 µm particle size, bridged ethyl hybrid C18; 
Waters) over a 2 h program with a gradient of 92% A (0.1% 
formic acid in water) and 8% B (0.1% formic acid in ace-
tonitrile) to 33% B, in 104 min at 300 nL min-1. LC-MS/MS 
analyses were performed in data-dependent mode to allow 
automatic selection of peptides for fragmentation. Tandem 
mass spectra were extracted using extract_msn (Thermo Fisher 
Scientific) executed in Mascot Daemon (version 2.4; Matrix 
Science). Mascot Deamon is a software that automate the file 
search on the Mascot server, and this task can also be performed 
Page 4 of 19
Wellcome Open Research 2020, 5:202 Last updated: 11 JAN 2021
on the Matrix Science website with one file at a time. Peak list 
files were searched against a modified version of the Uniprot 
mouse database (version 3.70; release date, 3 May 2011), 
containing ten additional contaminant and reagent sequences of 
non-mouse origin, using Mascot server (version 2.2.06; Matrix 
Science) that can be accessed using Matrix science website. 
Carbamidomethylation of cysteine was set as a fixed modifica-
tion; oxidation of methionine and hydroxylation of proline and 
lysine were allowed as variable modifications. Only tryptic 
peptides were considered, with up to one missed cleavage 
permitted. Monoisotopic precursor mass values were used, and 
only doubly and triply charged precursor ions were considered. 
Mass tolerances for precursor and fragment ions were 20ppm 
and 0.5 Da, respectively. MS datasets were validated using 
rigorous statistical algorithms at both the peptide and protein 
level implemented in Scaffold (version 3.6.5; Proteome 
Software). Protein identifications were accepted upon assign-
ment of at least two unique validated peptides with ≥90% 
probability, resulting in ≥99% probability at the protein level. 
These acceptance criteria resulted in an estimated protein false 
discovery rate of 0.1% for all datasets. Alternatively, peptide 
quantification and protein identification over the time course of 
insulin-induced INSR interactions was based on the precursor 
ion (MS1) intensities as a measure of protein abundance using 
Progenesis QI™ software (version 4.0). The quantification 
was based on 3 peptides per protein, and the identification was 
based on 2 peptides per protein. Raw data with identification 
and quantification outputs from the MS analyses have been 
deposited at Figshare33. The proteomic analysis tasks performed 
by Scaffold™ and Progenesis QI™ can be performed using 
MaxQuant, which is an open source software.
Protein interaction network analysis
The insulin receptor interactome was built from the protein- 
protein interaction public databases STRING (version 10.5) and 
BioGRID (version 3.4). Briefly, the INSR interaction network 
from both databases was downloaded at default settings for 
each database in Tab-delimited format. Data merging was 
performed using Microsoft Access 2011, and the evidence 
used for evaluating the confidence of interaction scores were 
primely found in the BioGRID imported file. This evidence was 
reviewed to reassess and re-score the interactions in the new 
network. A numerical scoring system was derived based on the 
type of experiment and amount of evidence. A low confidence 
interaction was given a score between 0.1–0.3 based on 1 piece 
of evidence from: 1) affinity capture-mass spectrometry, 2) yeast 
two-hybrid screen. A medium confidence interaction was given 
a score between 0.4–0.6 based on 2-3 pieces of evidence from 
the same categories as low confidence but with the addition of: 
1) affinity capture-immunoblot, 2) bioluminescence/fluorescence 
resonance energy transfer, 3) kinase activity, 4) phosphatase 
activity. A high confidence interaction was given a score 
between 0.7–0.9 based on more than 3 pieces of evidence from 
the same categories as low and medium confidence in addition 
to: 1) crystal structure reconstituted complex.
Ingenuity pathway analysis
Data were analysed through the use of Ingenuity Pathway 
Analysis (IPA; QIAGEN Inc.) to identify pathways predicted 
to be active in control and insulin treated samples over the 2, 7 
and 15 minute time course as previously described34. Perseus 
and Reactome software can be used to perform similar analysis 
to IPA, and the terminologies and the enriched pathways are 
similar between these software with some differences in the level 
of the classification terms.
Electrical cell-substrate impedance sensing assay
Electrical cell-substrate impedance sensing (ECIS) plates 
(Applied biophysics, 8W10E PET, catalogue number: 72010) 
were coated with extracellular matrix ligands type IV collagen 
(purified from human placenta, Sigma-Aldrich, catalogue 
number: C5533) and laminin (purified from human placenta, 
Sigma-Aldrich, catalogue number: L6274) (dissolved in 0.15 M 
NaCl) for 1 hour at room temperature, and then briefly washed 
with MilliQ H
2
O. The chambers were inserted into the ECIS 
instrument with serum-free media for 2 hours, and then the 
cells were seeded at equal numbers into the chambers and 
allowed to adhere for a minimum of 2 hours. Insulin or vehicle 
control were added directly to the wells without pausing the 
experiment, while supplementing the cells with full growth 
media required the removal of the plates from the instrument. 
The measurements were collected at 4000Hz according to the 
manufacturer instructions.
Immunofluorescence and image analysis
Cells on coverslips were washed with PBS and then fixed with 
4% (w/v) paraformaldehyde. Cells were permeabilised with 
0.5% (v/v) Triton X-100 and blocked with 3% (w/v) BSA in 
PBS before incubation with primary antibodies. Coverslips 
were mounted and images were collected using a CoolSnap 
HQ camera (Photometrics, Tucson, AZ, USA) and separate 
DAPI/FITC/Cy3 filters (U-MWU2, 41001, 41007a, respec-
tively; Chroma, Olching, Germany) to minimise bleed-through 
between the different channels. The images were collected using 
a Coolsnap HQ (Photometrics) camera with a Z optical spacing 
of 0.2µm. Images collected were viewed and analysed with Fiji 
(version 1.5)35.
Western blotting
All SDS-PAGE experiments were performed using NuPAGE® 
precast gels system (NuPage, Invitrogen) and the specifically 
designed apparatus by the same manufacturer. Protein samples 
were run into the gels at 150–200 volts for 40–60 minutes in 
1x Bolt™ MES running buffer. Following SDS-PAGE, sepa-
rated proteins were transferred onto nitrocellulose membrane 
(Whatman, Maidstone, UK). Membranes were blocked using 
casein blocking buffer (Sigma-Aldrich) for 1 hour at room 
temperature and probed with primary antibodies diluted in 
blocking buffer containing 0.05% (v/v) Tween-20 overnight 
at 4°C. The membranes were washed with PBS-Tween and 
incubated with species-specific fluorescent dye–conjugated 
secondary antibodies diluted in blocking buffer containing 
0.05% (v/v) Tween-20. Finally, the membranes were washed 
in dim lightning, and then scanned using the Odyssey infrared 
imaging system (LI-COR Biosciences, Cambridge, UK) to visual-
ise bound antibodies.
Statistical analysis
All error bars represent standard error of the mean (SEM) unless 
stated otherwise. For statistical analyses, one-way analysis of 
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variance (one-way ANOVA) was applied to compare means 
of more than two samples within the same experiment. The 
Student’s t-test was used, where appropriate, to directly 
compare between two samples. The clustering of the data used 
the Pearson uncentred assumption with complete linkage. 
The heat maps used the z-score (standardisation) to set the 
values within a manageable numerical range. The quantification 
of the proteomic data (ion intensity) was based on a minimum 
of three peptides, and the quantification was performed using 
Progenesis software (Progenesis QI, Nonlinear Dynamics). 
The statistical tests were performed using Microsoft Excel 2016 
and GraphPad Prism (version 7.0a) The proteomic statistical 
analysis performed by Progenesis QI™ could be performed using 
MaxQuant and Perseus software.
Results
In silico analysis of known INSR interactors
To generate a comprehensive INSR interaction network, an 
in silico INSR interactome was created by merging the INSR 
interactions from BioGRID and STRING databases and 
combining with a detailed review of the evidence associated 
with the BioGRID data (Figure 1). The interaction search was 
across mammalian cell and tissue systems and included 
experimental evidence of interaction but excluded predicted 
interactions. The network was designed in a spoke style where 
each node represents an INSR binder, and the three consecutive 
spoke rings are arranged according to the strength of evidence 
in the databases and corresponding support from published 
literature. Cumulative evidence for the different INSR interac-
tors in the network was manually re-evaluated and scored as 
described in the methods section. Furthermore, the generation 
of this network minimised the chances of missing some known 
INSR interactors by encompassing unique interactions that 
are found in one database but not the other. Gene Ontology 
(GO) analysis of the components of this network highlighted 
expected terms such as protein tyrosine kinase activity, receptor 
tyrosine kinase binding, and protein tyrosine phosphatase 
activity (Extended data Figure 133). This network and its 
GO terms were used as a reference in the assessment of our 
subsequent proteomic analysis of INSR interactors in podocytes.
Cultured podocytes are insulin sensitive
Wild type mouse podocytes were used to examine insulin 
induced INSR interactions by MS-based proteomics. To verify 
insulin sensitivity in these cells, we performed characterisation 
experiments. Western blotting demonstrated a good response 
to insulin stimulation (100 nM, 15 minutes), with increased 
phosphorylation of the INSR, and both the phosphoinositide-3 
kinase pathway (PI3K) pathway (phospho-IRS1 and -AKT473) 
and the mitogen-activated protein kinase (MAPK) pathway 
(phospho-MAPK42/44) compared to the basal state (Figure 2A). 
Furthermore, palmitate-induced insulin resistance resulted 
in the suppression of this response, in line with previously 
reported observations5. Insulin stimulation also prompted 
glucose uptake in podocytes, as demonstrated by uptake of 
the glucose analogue 2-NBDG, and this response was reduced 
upon palmitate induced insulin resistance (Figure 2B). Since 
the formation of the glomerular filtration barrier relies on 
interdigitating podocytes interacting with glomerular basement 
membrane (GBM) ligands, we used electrical cell-substrate 
impedance sensing (ECIS) to examine the barrier function of 
podocytes plated on either type IV collagen or laminin. We 
observed a response to insulin on both GBM ligands, where a 
drop in electrical resistance was recorded minutes after insulin 
stimulation followed by a recovery and stabilisation of the 
monolayer (Figure 2D, 2E). Palmitate induced insulin resistance 
resulted in a much lower electrical resistance compared to 
basal conditions, and a complete loss of response to insulin 
stimulation. Together these findings confirm insulin sensitivity in 
cultured podocytes, with changes in cellular signalling, glucose 
uptake and barrier function. Furthermore, these responses 
were lost with palmitate induced insulin-resistance.
Immunoprecipitation of the INSR and detection by 
mass spectrometry
The endogenous INSR was isolated from mouse podocytes 
using antibody-based immunoprecipitation (IP), where the 
receptor was targeted by antibodies recognising the intracel-
lular (β subunit), (Figure 2C). Insulin receptor substrate 1 
(IRS1) was primarily used to monitor the co-IP of known INSR 
interactors by western blotting. Although the INSR and some 
interactors were detectable by western blotting, analysis by 
mass spectrometry yielded only low levels of the endogenous 
INSR. To scale up the isolation of the receptor, immortalised 
human podocytes overexpressing the human insulin receptor 
(hWT-IR) were used to isolate the INSR. As previously 
reported36 our functional evaluation of the hWT-IR cells 
demonstrated insulin responsiveness as shown by the activity 
of PI3K and MAPK, and the 2-NBDG uptake; however, these 
cells did not become insulin resistant in the presence of 
palmitate (Extended data Figure 2A-B33). Importantly, co-IP of 
the INSR and some of its known interactors was reproducible 
in the hWT-IR cells (Extended data Figure 2C33), and the MS 
analysis of the INSR complex demonstrated the dominance of 
the INSR peptides. The MS analysis of the INSR complexes 
15 minutes after insulin stimulation identified a number of 
known INSR interactors and to further improve the likelihood 
of detecting known INSR interactors in the proteomic analysis, 
the INSR was isolated after a time course of 2, 7, and 15 min-
utes of insulin stimulation (Extended data Figure 3 and Extended 
data Table 133). This resulted in the detection of the INSR 
and 26 of its known interactors that were found in the INSR 
in silico network (Extended data Table 133), and these 26 
interactors were found across two independent MS experiments. 
The identification of known INSR interactors such as IRS1, 
IGF1, GRB10, CAV1 and PTPN1 increased our confidence in 
identified interactors in the proteomic dataset.
Proteomic analysis of INSR complex revealed novel 
interactors
Protein identification and relative quantification over the time 
course of insulin-induced INSR interactions was based on 
the precursor ion (MS1) intensities as a measure of protein 
abundance, and the analysis was performed using Progenesis 
QI™ software. Quantification was based on 3 peptides per 
protein, and identification was based on 2 peptides per protein. 
The resulting protein list was analysed using four approaches: 
a) network analysis of the known INSR interactors to identify 
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Figure 1. The in silico analysis of known INSR interactors. The analysis of the INSR interactome in silico based on protein-protein 
interactions obtained from two public databases (STRING (version 10.5) and BioGRID (version 3.4). INSR interactors were arranged in 3 
consecutive circles according the level of confidence in supporting evidence of the interaction. A numerical scoring system was used to 
grade evidence on the basis of the type of experiment and the amount of evidence (see methodology). The node size reflects the amount of 
evidence and the node colour indicates the level of confidence score for the interaction. The node border indicates whether the interaction 
was detected in a low or high throughput experiment and the colour of the edges represents the level of confidence in the interaction.
Page 7 of 19
Wellcome Open Research 2020, 5:202 Last updated: 11 JAN 2021
Figure 2. Podocytes are insulin sensitive. (A) Cultured differentiated mouse wild-type (mWT) podocytes are insulin responsive and can 
activate the PI3K and MAPK pathway. In the presence of palmitate, the cells became insulin resistant with reduced activity of both pathways. 
(B) Podocytes responded to insulin stimulation by initiating 2-NBDG uptake (a glucose analogue) up to three-fold compared to the basal 
condition, which was lost in the palmitate treatment. (C) The insulin receptor (INSR) was isolated using immunoprecipitation, and the insulin 
receptor substrate 1 (IRS1) was co-immunoprecipitated with the receptor. (D and E) The electrical resistance formed by the adhesion of 
podocytes to laminin and collagen and their formation of a monolayer-like layer measured by electrical cell-substrate impedance sensing 
(ECIS).
connections between these proteins and other proteins in the 
dataset, b) clustering analysis to identify patterns of recruitment, 
c) generation of INSR interactor groups based on identification 
confidence and increase following insulin stimulation and 
d) Ingenuity Pathway Analysis (IPA) analysis to identify 
significant terms and molecular functions associated with INSR 
interactors.
Firstly, the 26 known INSR interactors identified from the 
proteomic dataset and mapped onto the in silico INSR were 
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inter-linked with the rest of the proteins within the dataset to 
discover new interactions. This approach was limited to 500 
proteins per search using the STRING database. To highlight 
potential false positive identifications the resulting network 
was then searched against the Contaminant Repository for 
Affinity Purification5 since immunoprecipitation can result in 
the co-isolation of non-specific interactions. The list was then 
sub-divided into three categories to express the chances of 
detecting background proteins as a percentage according to the 
total number of experiments in the list (total of 411). As such a 
protein with a score between 0-4 experiments would have a 
chance up to 1% of being a random protein, 5-41 would be 
up to 10% chance, and 42-411 would be up to 100% chance of 
a particular protein being a false positive being detected in 
nearly all 411 experiments. This step was useful in avoiding 
potential false positives and guided the analysis process. This 
first approach highlighted indirect interactions of the INSR that 
may be significant in podocyte biology such as CNN1, PTPN14, 
and MARK2 and MARK3 (Figure 3A).
The second clustering approach focused on identifying proteins 
with similar temporal profiles of recruitment to the INSR upon 
insulin stimulation. Hierarchical clustering of the dataset was 
based on the normalised ion intensities (Pearson uncentred, 
complete linkage), and the selection of clusters of interest by 
finding known INSR binders in the dataset and then extracting 
these clusters with a correlation value no less than (0.7) 
(Figure 3B). Each of the extracted clusters was interrogated 
against the STRING database to identify any established 
interactions between the cluster components, and the associated 
Gene Ontology terms associated with them. This approach 
did not yield proteins that behaved in a similar manner to some 
of the known INSR interactors.
The third approach created INSR interactor groups by 
applying filters. Proteins were filtered based on the number of 
peptides per protein (minimum of 2 or 3 unique peptides), fold 
change, p-value, and overlap with contaminant databases. 
Volcano plots of the abundance (i.e. association/dissociation 
with the INSR) of the different proteins across the different 
time points versus the significance (p-value) highlighted 
proteins that follow specific regulation patterns in terms of 
interaction with the INSR (Figure 4A–C); for instance, VAPA and 
VAPB (Vesicle-associated membrane protein-associated protein 
A and B respectively) showed an increased association with 
the INSR as a function of time after insulin stimulation, and the 
profiles of proteins such as XPO1 (Exportin-1) and CORO1C 
(Coronin-1C) indicated dissociation from the INSR soon after 
insulin stimulation. Moreover, the Contaminant Repository for 
Affinity Purification dataset was utilised as a filter to reduce 
the chances of pursuing false positives (Figure 4D). This 
analytical approach yielded a number of candidates that 
display specific abundance changes at the different time points 
including GRB10 and XPO1 at 2 minutes, VAPA and VAPB 
at 7 minutes and VPS13A and MTCL1 at 15 minutes.
Finally, analysis of the data using Ingenuity Pathway Analysis 
(IPA) was used to gain further insight into the possible 
connections and significant terms associated with proteins 
in the different sub-lists. The search resulted in highlighting 
multiple terms and signalling pathways that are relevant 
to podocyte biology and insulin signalling including the 
ERK/MAPK network and PI3K/AKT network (Extended 
data Figure 4 and 533). The diseases and biological function 
top terms were mostly linked to microtubules and the actin 
cytoskeleton.
In summary, the combined analysis of the time course data 
provided insights into the temporal regulation of the INSR 
and the dynamic nature of protein interactions. Moreover, 
the varied analytical approaches were complementary and 
enabled us to view the data from different perspectives. 
The analysis process resulted in shortlisting of proteins that 
fall under three main categories: microtubules and actin 
regulation, vesicle trafficking, and kinase/phosphatase activity. 
The doublecortin containing protein 2 (DCDC2) was selected 
as a potential novel INSR interactor within the microtubule 
and actin regulation category, due to high abundance, response 
to insulin stimulation, and not reported in the Contaminant 
Repository for Affinity Purification of potential contaminants37.
DCDC2 co-immunoprecipitated and co-localised with the 
INSR
To confirm the interaction of DCDC2 with the INSR, 
co-immunoprecipitation of DCDC2 with the INSR was performed 
in human wild type podocytes. DCDC2 co-immunoprecipitated 
with the INSR, but not integrin β1 upon insulin stimulation. 
Integrin β1 is not known to interact with DCDC2 and its 
interactome is well studied38 (Figure 5A). DCDC2 is involved 
with the formation of microtubules and increased expression 
has been associated with stabilisation of podocyte microtu-
bules39. To understand the connection between insulin signalling, 
and podocyte cytoskeletal remodelling in response to insulin 
stimulation, we used nocodazole to disrupt microtubules. 
Furthermore, we examined the effect of palmitate induced 
insulin resistance in podocytes, to examine effects on the 
interaction between INSR and DCDC2. The presence of 
palmitate enhanced the interaction between the INSR and 
DCDC2, while the disruption of microtubules using nocodazole 
abrogated this interaction. Interestingly, palmitate stabilised 
the interaction between of DCDC2 and INSR even after the 
disruption of microtubules (Figure 5A). Immunofluorescence 
analysis of intensity profiles of INSR and DCDC2 showed 
similar distributions of elevated signal indicating close 
proximity of these proteins within the podocyte (Figure 5B). 
In addition, focusing on cellular projections showed that the 
INSR and DCDC2 clustered along the projection edge, and 
this clustering is reduced after insulin stimulation (Figure 5C). 
Overall these findings support an interaction between the 
INSR and DCDC2 and altered association following insulin, 
palmitate or nocodazole stimulation.
DCDC2 localised to mitotic spindles and primary cilia in 
proliferating podocytes
To gain further insight into the localisation of DCDC2 
in podocytes, we performed immunofluorescence imag-
ing of DCDC2 in proliferating and differentiated podocytes 
since these cells adopt different morphologies between the 
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Figure 3. Proteomic analysis of INSR interactors in podocytes. (A) A one-hop analysis of the INSR proteomic data linking the detected 
known INSR binders to other identified proteins in the dataset. The network was further mapped onto the Contaminant Repository for 
Affinity Purification to discriminate between background hits and potential novel candidates. (B) A heat map of the proteins with a minimum 
of 2 unique peptides (Pearson uncentred and complete linkage). Clusters containing known INSR binders (arrows) were extracted with a 
minimum of (0.7) correlation score to discover complexes and pathways.
Page 10 of 19
Wellcome Open Research 2020, 5:202 Last updated: 11 JAN 2021
Figure 4. Distribution and abundance of INSR interactors. (A–C) Volcano plots demonstrating the association/dissociation of the 
different proteins with the INSR at the different time points. The differences in fold change of proteins at each time point are relative to the 
basal condition (time =0, no insulin stimulation). (D) a scatter plot detailing the chances of the detected proteins being non-specific interactors 
based on 411 experiment from the Contaminant Repository for Affinity Purification database, where proteins with low contaminant scores 
and high peptide counts are less likely to be false positive interactors.
differentiation states13. Under proliferating conditions, the dis-
tribution of DCDC2 was uniform across the cell body with 
intense signals at structures resembling primary cilia and mitotic 
spindles (Extended data Figure 633). This pattern became less 
obvious during differentiation of podocytes, where the long 
primary cilia structure became much smaller, and since the 
cells halt mitotic activity after differentiation, there were few 
mitotic spindles. In addition, we found that insulin stimulation 
initiated cortical microtubule formation, and the localisation of 
DCDC2 followed these microtubular changes; however, there 
was no significant reorganisation of DCDC2 following insulin 
stimulation (Extended data Figure 733). These observations 
further highlight a possible role for DCDC2 in podocyte 
cytoskeletal function.
DCDC2 knockdown caused distinct morphological 
change in podocytes
Transient knockdown of DCDC2 by siRNA in podocytes 
resulted in significant morphological change compared to 
control conditions, where knockdown cells resembled a flat-
tened phenotype on type IV collagen and to a lesser extent 
on laminin (Figure 6A and 6B). To further understand this 
observation in relation to the INSR, we examined the trans-
fected cells using immunofluorescence imaging. We observed 
that the INSR signal was intense at the cell membrane in 
knockdown cells compared to control cells, which had a more 
uniform localisation pattern. As expected the DCDC2 signal 
was reduced in knockdown cells (Figure 6C). Overall these 
findings reinforce a link between the INSR-DCDC2 interaction 
and podocyte cytoskeletal dynamics.
Discussion
In this study we defined an in silico interaction network for the 
INSR across multiple tissues and focussed on the glomerular 
podocyte to identify novel INSR interactors. We confirmed 
that podocytes are insulin sensitive cells and become insulin 
resistant on stimulation with palmitate. Using INSR immuno-
precipitation and MS-based proteomics we discovered DCDC2 
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Figure 5. DCDC2 interacts and co-localises with the INSR in podocytes. (A) DCDC2 co-immunoprecipitated with the INSR isolated 
from hWT-IR podocytes. Palmitate stabilised the interaction of DCDC2 with the INSR, while disrupting microtubules with nocodazole 
abrogated the interaction between the INSR and DCDC2. (B–C) Immunofluorescence imaging of DCDC2 and the INSR in differentiated 
hWT-IR podocytes showed perinuclear co-localisation and also at the processes of the podocytes as demonstrated by the line profile. 
DCDC2: Doublecortin containing protein 2, ITGB1: Integrin beta 1.
as a novel INSR interactor in podocytes and we propose that 
this microtubule-associated protein may have a role in regulating 
the podocyte in response to insulin stimulation.
Insulin signalling is key for normal podocyte function11 and it is 
disrupted in DKD2. During the evolution of DKD, podocytes 
become flattened or effaced, however the underling mechanisms 
for this change in morphology are not well understood. This 
study focused on the insulin signalling pathway in podocytes at 
the receptor level, using affinity-enrichment over a 2–15 minute 
time course following insulin stimulation. The bioinformatic 
analysis led to the identification of doublecortin containing 
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Figure 6. DCDC2 knockdown disrupts INSR distribution and podocyte morphology. (A) DCDC2 was knocked down (kd) using pooled 
siRNA that achieved more than 70% reduction in the protein expression in proliferating podocytes after 2 rounds of siRNA transfection 
(2x siRNA). (B) The morphology of DCDC2-kd podocytes differed significantly compared to normal conditions when spread on collagen 
IV as demonstrated by the phase contrast imaging. (C) The INSR in the DCDC2-kd podocytes was localised to the plasma membrane 
especially after insulin stimulation. DCDC2: Doublecortin containing protein 2.
protein 2 (DCDC2) as a novel INSR binding protein. The rational 
for choosing this candidate for follow-up studies was based on 
the morphological change that podocytes undergo in DKD. These 
changes, which include foot process effacement, are associated 
with insulin signalling as demonstrated by podocyte-specific 
INSR knockout or the INSR in transgenic mice11. These mice 
developed a phenotype that mimicked the pathological change 
seen in DKD, with albuminuria and podocyte effacement but 
in the context of normoglycemia. This observation implies that 
signalling from the INSR itself might be required for 
maintaining the cytoskeletal architecture of the podocyte, and 
hence DCDC2 could represent a link between the INSR and 
cytoskeletal regulation.
The interaction of DCDC2 with the INSR was confirmed by 
immunoprecipitation, and co-localisation of the two proteins 
was demonstrated by immunoprecipitation and imaging. More-
over, under insulin resistance conditions, DCDC2 displayed 
increased association with the INSR, and the disruption of micro-
tubules led to complete loss of this interaction. DCDC2 has 
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been linked previously to microtubule stability in podocytes39; 
however, this is the first time that this protein has been linked 
to insulin signalling and the INSR. The siRNA knockdown of 
DCDC2 in podocytes resulted in abnormal cellular localisation 
of the INSR, compared to controls, together with morphological 
changes. These observations suggest that the relation between 
DCDC2 and INSR could be related to intracellular trafficking 
especially following insulin stimulation. The hWT-IR cell line 
did not become insulin resistant upon stimulation with palmitate 
and this may be related to high levels of the INSR due to 
overexpression. However, the presence of palmitate also had a 
clear effect on the interaction between DCDC2 and INSR. One 
explanation for this observation is that the DCDC2 interaction 
with the INSR is stabilised by palmitate; tipping the balance 
between the association and dissociation state.
DCDC2 in the context of kidney diseases is linked to renal 
ciliopathies and nephronophthisis; however, insulin signalling 
is not directly linked to these disorders40,41. The detection of 
DCDC2 at structures that resembled primary cilia and also at 
mitotic spindles by immunofluorescence imaging indicates that 
DCDC2 might play multiple biological functions in proliferat-
ing podocytes. These structures are not observed in differen-
tiated podocytes, and DCDC2 does not seems to re-localise 
in response to insulin signalling. Podocytes have been reported 
to adopt different morphologies when seeded onto different 
extracellular matrix ligands42; however, the knockdown of 
DCDC2 resulted in significant morphological changes when 
the cells were plated on laminin or type IV collagen com-
pared to the controls. This indicates the possibility of a role of 
DCDC2 in specific protein networks that dictate the podocyte 
morphological adaptation in response to outside-in signalling 
and might represent a convergence with insulin signalling.
In conclusion, this study provides insight into both the 
complexity and specificity of insulin signalling in podocytes. 
Furthermore, it may explain how insulin resistance can affect 
the integrity of the glomerular filtration barrier in kidney 
disease associated with and insulin resistant states, such as 
DKD. The bioinformatic analysis of the INSR complex led 
to the discovery of expected and novel INSR interactors and 
confirmation of DCDC2 as a novel INSR binding protein. 
Further investigation of the link between the insulin signal-
ling, DCDC2 and podocyte cytoskeletal regulation may lead 
to improved understanding about mechanisms that underlie 
podocyte dysfunction in DKD.
Data availability
Underlying data
Figshare: Proteomic analysis of insulin receptor interactors 
in glomerular podocytes. https://doi.org/10.6084/m9.figshare.
c.5015879.v433
This project contains the following underlying data:
-      Final Supp data Progenesis QI INSR_TIME_COURSE.xlsx 
(Progenesis QI output files)
-      Progenesis QI INSR_TIME_COURSE.xlsx (Progenesis 
QI output files)
-      Scaffold proteomics INSR_TIME_COURSE.xls (Mascot 
and Scaffold analysis output as spectral counts)
-      20161125_RL_SH_02.raw (INSR IP LC-MSMS data 
RAW files time 0 min)
-      20161125_RL_SH_03.raw (INSR IP LC-MSMS data 
RAW files time 0 min)
-      20161125_RL_SH_04.raw (INSR IP LC-MSMS data 
RAW files time 0 min)
-      20161125_RL_SH_05.raw (INSR IP LC-MSMS data 
RAW files time 0 min)
-      20161125_RL_SH_06.raw (INSR IP LC-MSMS data 
RAW files time 2 min)
-      20161125_RL_SH_07.raw (INSR IP LC-MSMS data 
RAW files time 2 min)
-      20161125_RL_SH_08.raw (INSR IP LC-MSMS data 
RAW files time 2 min)
-      20161125_RL_SH_09.raw (INSR IP LC-MSMS data 
RAW files time 2 min)
-      20161125_RL_SH_10.raw (INSR IP LC-MSMS data 
RAW files time 7 min)
-      20161125_RL_SH_11.raw (INSR IP LC-MSMS data 
RAW files time 7 min)
-      20161125_RL_SH_12.raw (INSR IP LC-MSMS data 
RAW files time 7 min)
-      20161125_RL_SH_11_161126202211_15.raw (INSR IP 
LC-MSMS data RAW files time 7 min)
-      20161125_RL_SH_12_161126222443_16.raw (INSR IP 
LC-MSMS data RAW files time 15 min)
-      20161125_RL_SH_13_161127002717_17.raw (INSR IP 
LC-MSMS data RAW files time 15 min)
-      Figure 2 (Original western blotting)
-      Figure 2 (Original IP)
-      Figure 5 (Original IF Images)
-      Figure 5 (Original western blotting and IP)
-      Figure 6 (Original IF Images)
-      Figure 6 (Original western blotting)
-      Figure 6 (Phase contrast images)
-      Extended data - Figure 2 (Original western blotting)
-      Extended data - Figure 3 (Original western blotting and 
IP)
-      Extended data - Figure 6 (Original IF Images)
-      Extended data - Figure 7 (Original IF Images)
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Figshare: Proteomic analysis of insulin receptor interactors 
in glomerular podocytes. https://doi.org/10.6084/m9.figshare.
c.5015879.v433
This project contains the following extended data:
-      Extended data figures.pdf (Extended data Figures)
-      ExtendedDataTable1.pdf (Extended data – Table 1)
-      ExtendedDataTable2.pdf (Extended data – Table 2)
Extended data Table 1. Time course insulin stimulation. 
Podocytes were stimulated with 100 nm insulin for 2,7 and 
15 minutes. Total spectral counts (TSC) are indicated for each 
replicate sample. Molecular Weight = MWt, kilo Dalton = kDa, 
Minutes = ‘.
Extended data Table 2. The insulin receptor and 26 of its 
known interactors that were also found in the INSR in silico 
network. These 26 interactors were found across two independent 
experiments. 
Extended data Figure 1. (A) Literature known insulin receptor 
interactors form a highly interconnected network. (B) Gene 
Ontology (GO) analysis of the components of this network 
highlighted expected terms such as protein tyrosine kinase 
activity, receptor tyrosine kinase binding, and protein tyrosine 
phosphatase activity.
Extended data Figure 2. (A) Human wild type podocytes over 
expressing the insulin receptor (hWT-IR) are insulin responsive 
and yielded good amounts of the INSR with immunopre-
cipitation. (B) hWT-IR cells responded to insulin stimula-
tion with an increase in glucose uptake but they did not become 
insulin resistant in the presence of palmitate. (C) Co-IP of the 
INSR and some of its known interactors was reproducible in the 
hWT-IR cells.
Extended data Figure 3. (A) an illustration of the workflow 
for the generation of the main proteomic dataset. (B) Immuno-
precipitation of the INSR from hWT-IR podocytes at different 
time points demonstrating co-immunoprecipitation of phos-
pho-IRS1. (C) The mapping of detected known INSR interactors 
from two experiments onto the in silico INSR network.
Extended data Figure 4. Ingenuity pathway analysis (IPA) was 
used to gain further insight into the possible connections and 
significant terms associated with proteins in the different sub-
lists. (A) High level view of signalling pathways altered across 
the early (2 minute), intermediate (7 minute) and late (15 minute) 
time points. (B) Genes is the signalling by Rho family GTPases 
pathway. (C) Genes in the RhoA signalling network. (D) Genes in 
the ERK/MAPK signalling network and (E) Genes in the PI3K/
AKT signalling network.
Extended data Figure 5. Ingenuity pathway analysis (IPA) 
was used to gain further insight into the possible connections 
and significant terms associated with proteins in the different 
sub-lists. (A) High level view of diseases and biological 
function pathways altered across the early (2 minute), intermedi-
ate (7 minute) and late (15 minute) time points. (B) Genes in the 
quantity of actin stress fibres cluster. (C) Genes in the quantity of 
actin filaments cluster.
Extended data Figure 6: DCDC2 co-localised with microtu-
bules and clustered in primary cilia and mitotic spindles. (A) The 
immunofluorescence of DCDC2 demonstrated the cellular 
distribution and co-localisation with microtubules, primary 
cilia, and mitotic spindles in proliferating hWT-IR podocytes. 
(B) DCDC2 shows a slight overlap with the insulin receptor that 
does not change with insulin stimulation. (40x magnification).
Extended data Figure 7: DCDC2 co-localised with microtubules 
in differentiated human podocytes. (A) The immunofluorescence 
of DCDC2 demonstrated a cellular distribution resembling 
microtubular filaments. (B) DCDC2 and microtubules co-staining 
demonstrated the co-localisation of the two proteins, and insulin 
stimulation did not influence the localisation DCDC2. 
Data are available under the terms of the Creative Commons 
Zero “No rights reserved” data waiver (CC0 1.0 Public domain 
dedication).
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